Asso. Prof. Dr. Lim Ren Jye

Dr. Lim Ren Jye earned his MBBS from International Medical University (IMU), Malaysia. After completing housemanship, hereceived the Malaysia Ministry of Health Scholarship andlater pursuedhis Masters in Integrated Medicine (Clinical-Herbal Oncology) at Shanghai University of Traditional Chinese Medicine (SHUTCM), China. In 2009, SHUTCM awarded him theShanghai Municipal Scholarship inhonor ofhispassion towardsclinical practice and his academic accomplishments.In 2011, Dr. Lim served the Traditional and Complementary Medicine Division, Ministry of Health Malaysia in his position as Senior Assistant Director where he was actively involved in the development of suitable policies that work to promote T&CM in the country.In 2013, Dr. Lim was appointedas Head of the T&CM Unit at the National Cancer Institute (NCI). During his full time tenure at NCI, Dr. Lim continued to provide consultations at Kepala Batas Hospital, Penang (monthly basis) and Tung Shin Hospital, Kuala Lumpur (weekly basis). In 2018, he obtained his PhD in Chinese Medicine from Nanjing University of Chinese Medicine (NJUCM).Besides clinical works, Dr Lim is also holding position as visiting Aassociate Professor at China Shanghai University of Traditional Chinese Medicine and Lecturer at Malaysia International Medical University. He is also committed in giving public talks and volunteering at NGOs such as the Tzu Chi Foundation and various cancer support groups to instilawareness on cancer and good health care services. His passion has led him to his current reign as the Deputy Chairman of the Palliative Technical Committee in the World Federation of Chinese Medicine Societies (WFCMS), President of Malaysia SHUCTM Alumni Association,panel member with the Malaysia Qualifications Agency and a member of Malaysia Medical Council (MMC) and the Malaysia Chinese Medicine Association (MCMA).Dr. Lim is also enthusiastic about T&CM research wherehe has participated as principal investigator or co-investigator, consultant and external reviewer to various publications related to the use of Chinese medicine in the treatment of cancer. His contributions to research have been acknowledged in Malaysian Health Technology Assessments, Science Citation Index (SCI) journals, handbooks and Clinical Practice Guidelines (CPGs).